antibodies
| 4 min read
Investigating antibodies produced by infectious diseases yields vaccines with broad-acting protection.
Available on Demand
LIVE June 30th, 2021 at 2:30 PM ET
In this webinar, scientists will discuss the emergence of SARS-CoV-2 variants and strategies for monitoring, tracking, and mitigating SARS-CoV-2 escape variants.
Available on Demand
LIVE June 22nd, 2021 at 2:30 PM ET
This webinar will explore recent discoveries about the way the immune system responds to SARS-CoV-2 infection.
| 1 min read
Infectious diseases alter the traditional vaccine pipeline and spawn new approaches to antibody research and vaccine development.
Available on Demand
LIVE May 20th, 2021 at 2:30 PM ET
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.
In this webinar, Berkeley Lights scientists present a new platform for antibody discovery and cell line development that accelerates the identification and production of leading therapeutic molecules.
| 2 min read
Therapeutic candidates retain binding to major COVID-19-causing “South African” variant
| 4 min read
Yurogen and Asuragen acquisitions expected to aid wide range of researchers
| 4 min read
The anti-CD117 antibody is being evaluated as a conditioning agent prior to blood stem cell transplantation
| 3 min read
Two leading scientists call on health agencies to invest in broadly effective vaccines
